Fluid Resuscitation with 5% albumin versus Normal Saline in Early Septic Shock: A pilot randomized, controlled trial

Journal of Critical Care

Volumn 27, Issue 3, 2012, Pages 317.e1-317.e6

  McIntyre, Lauralyn A ^a   Fergusson, Dean A ^a   Cook, Deborah J ^a   Rowe, Brian H ^a   Bagshaw, Sean M ^a   Easton, Dave ^a   Emond, Marcel ^a   Finfer, Simon ^a   Fox Robichaud, Alison ^a   Gaudert, Claude ^a   Green, Robert ^a   Hebert, Paul ^a   Marshall, John ^a   Rankin, Nigel ^a   Stiell, Ian ^a   Tinmouth, Alan ^a   Pagliarello, Joe ^a   Turgeon, Alexis F ^a   Worster, Andrew ^a   Zarychanski, Ryan ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Albumin; Fluid resuscitation; Septic shock

Indexed keywords

ACTIVATED PROTEIN C; ADRENALIN; ALBUMIN; CORTICOSTEROID DERIVATIVE; DOBUTAMINE; DOPAMINE; HYPERTENSIVE FACTOR; MILRINONE; NORADRENALIN; PHENYLEPHRINE; SODIUM CHLORIDE; VASOPRESSIN;

ADULT; AGE; AGED; APACHE; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EMERGENCY WARD; FEASIBILITY STUDY; FEMALE; FLUID RESUSCITATION; HOSPITAL ADMISSION; HUMAN; HYPOTENSION; INFORMED CONSENT; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; SEPTIC SHOCK; TREATMENT DURATION;

EID: 84861194059     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2011.10.007     Document Type: Article

References (15)

1. Levy M.M., Dellinger R.P., Townsend S.R., et al. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med 2010, 36(2):222-231.
2. Schortgen F., Lacherade J.C., Bruneel F., et al. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 2001, 357(9260):911-916.
3. Brunkhorst F.M., Engel C., Bloos F., et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008, 358(2):125-139.
4. Zarychanski R., Turgeon A., Fergusson D., et al. Renal outcomes and mortality following hydroxyethyl starch resuscitation in critically ill patients: a systematic review and meta-analysis of randomized trials. Open Medicine 2009, 3(4):E196-E209.
5. Dart A.B., Mutter T.C., Ruth C.A., Taback S.P. Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Database Syst Rev 2010, (1):CD007594.
6. Finfer S., McEvoy S., Bellomo R., McArthur C., Myburgh J., Norton R. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Med 2011, 37(1):86-96.
7. Delaney A.P., Dan A., McCaffrey J., Finfer S. The role of albumin as a resuscitation fluid for patients with sepsis: a systematic review and meta-analysis. Crit Care Med 2011, 39(2):386-391.
8. Bone R.C. Let's agree on terminology: definitions of sepsis. Crit Care Med 1991, 19:973-976.
9. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960, 20(1):37-46.
10. McIntyre L.A., Fergusson D., Cook D.J., et al. Fluid resuscitation in the management of early septic shock (FINESS): a randomized controlled feasibility trial. Can J Anesth 2008, 55(12):819-826.
11. Cook D.J., Rocker G., Meade M., et al. Prophylaxis of Thromboembolism in Critical Care (PROTECT) Trial: a pilot study. J Crit Care 2005, 20(4):364-372.
12. Hebert P.C., Chin-Yee I., Fergusson D., et al. A pilot trial evaluating the clinical effects of prolonged storage of red cells. Anesth Analg 2005, 100(5):1433-1438. table.
13. Cook D., Meade M., Guyatt G., et al. PROphylaxis for ThromboEmbolism in Critical Care Trial protocol and analysis plan. J Crit Care 2011, 26(2):223-229.
14. Lacroix J., Hebert P., Fergusson D., et al. The Age of Blood Evaluation (ABLE) randomized controlled trial: study design. Transfus Med Rev 2011, 25(3):197-205.
15. Myburgh J. CHEST and the impact of fraud in fluid resuscitation research. Crit Care Resusc 2011, 13(2):69-70.